Bristol-Myers Squibb Company
BMY
$46.55
$0.621.35%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.70B | 47.64B | 48.30B | 47.44B | 46.51B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.70B | 47.64B | 48.30B | 47.44B | 46.51B |
| Cost of Revenue | 12.44B | 12.06B | 11.95B | 11.44B | 11.08B |
| Gross Profit | 35.26B | 35.58B | 36.35B | 35.99B | 35.43B |
| SG&A Expenses | 7.20B | 7.44B | 7.82B | 8.03B | 7.89B |
| Depreciation & Amortization | 5.76B | 7.35B | 8.87B | 9.46B | 9.31B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.04B | 36.51B | 38.43B | 38.41B | 37.57B |
| Operating Income | 12.66B | 11.13B | 9.88B | 9.03B | 8.94B |
| Income Before Tax | 6.59B | 6.11B | -8.38B | -6.88B | -6.42B |
| Income Tax Expenses | 1.53B | 671.00M | 554.00M | 367.00M | 109.00M |
| Earnings from Continuing Operations | 5.07K | 5.44K | -8.93K | -7.25K | -6.53K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.00M | -18.00M | -15.00M | -11.00M | -13.00M |
| Net Income | 5.05B | 5.42B | -8.95B | -7.26B | -6.54B |
| EBIT | 12.66B | 11.13B | 9.88B | 9.03B | 8.94B |
| EBITDA | 19.14B | 19.22B | 19.45B | 19.21B | 18.95B |
| EPS Basic | 2.49 | 2.67 | -4.43 | -3.59 | -3.25 |
| Normalized Basic EPS | 3.91 | 3.45 | 3.07 | 3.04 | 3.10 |
| EPS Diluted | 2.47 | 2.66 | -4.43 | -3.60 | -3.26 |
| Normalized Diluted EPS | 3.90 | 3.44 | 3.07 | 3.04 | 3.09 |
| Average Basic Shares Outstanding | 8.12B | 8.12B | 8.11B | 8.11B | 8.13B |
| Average Diluted Shares Outstanding | 8.15B | 8.14B | 8.12B | 8.12B | 8.15B |
| Dividend Per Share | 2.46 | 2.44 | 2.42 | 2.40 | 2.37 |
| Payout Ratio | 98.12% | 90.59% | -54.35% | -66.20% | -73.08% |